Are Teva Pharmaceutical (NYSE:TEVA) Shares Headed North? BTIG Research Issues Upgrade

Teva Pharmaceutical on the Street Analysts’ Recommendations in September

Teva Pharmaceutical Industries Limited - Receive News & Ratings Daily

About 34.48M shares traded or 12.28% up from the average. The stock's market capitalization is $19.56 billion. It closed at $14.37 lastly. (NASDAQ:ULBI) has risen 59.57% since September 11, 2016 and is uptrending. It has outperformed by 0.38% the S&P500. First City Capital Management Inc acquired 14,635 shares as Teva Pharmaceutical Inds (TEVA)'s stock declined 15.11%. Teva Pharmaceutical Inds now has $18.94B valuation. The stock rose 21.75% or $3.37 reaching $18.87 per share. A total volume of 98.33 million shares were traded versus to average volume of 16.58 million shares. Insiders contain to comply with strict disclosure requirements with regard to the sale or purchase of the shares of their company. On Monday, June 5 the insider PELTZ NELSON sold $87.84M. Peltz Matthew H. sold $87.84 million worth of stock.

The previous rating of a Neutral for Teva Pharmaceutical (NYSE:TEVA) has been discontinued as BTIG Research raised TEVA's current rating to a respectable Buy. Therefore 25% are positive. PPG Industries had 39 analyst reports since September 6, 2015 according to SRatingsIntel. The company was downgraded on Friday, January 6 by Longbow. Cowen & Co downgraded the stock to "Market Perform" rating in Friday, August 4 report. The company saw a fall in short interest between July 31, 2017 and August 15, 2017 of -8.67%. The firm has "Buy" rating given on Friday, May 26 by Jefferies. CACQ has analyst rating of 1.00 on scale of 1-5. Overall, volume was up 1,432.29% over the stocks normal daily volume. The firm has "Buy" rating by Citigroup given on Tuesday, July 28.

Investors sentiment increased to 1.41 in 2016 Q4. Its down 0.26, from 1.18 in 2016Q3. Mitsubishi Ufj Trust And Banking Corp, a Japan-based fund reported 264,425 shares. Finally, JFS Wealth Advisors LLC boosted its position in Teva Pharmaceutical Industries Limited by 139.0% in the third quarter. Hightower Advisors Llc holds 0% or 33,845 shares. "It is good that a CEO from the industry has arrived, and good that he is coming over overseas, because that delivers a soothing message to foreign investors", she adds. The Ohio-based Huntington National Bank has invested 0.01% in the stock. This represents a $0.34 dividend on an annualized basis and a yield of 1.84%. (NASDAQ:LSTR). Alliancebernstein Lp holds 0% of its portfolio in Landstar System, Inc. Five investment analysts have rated the stock with a sell rating, nineteen have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Teva Pharmaceutical Industries Limited has a 1-year low of $15.22 and a 1-year high of $52.66. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has "Buy" rating given on Monday, November 23 by Goldman Sachs. The company was initiated on Thursday, September 29 by OTR Global. Barclays Capital has "Equal-Weight" rating and $69 target.

08/03/2017 - Teva Pharmaceutical Industries Limited had its "neutral" rating reiterated by analysts at Piper Jaffray. Deutsche Bank maintained it with "Buy" rating and $54 target in Wednesday, November 16 report.

Teva has been searching for a new, permanent CEO since February, when former boss Erez Vigodman left the company. When analyzing small corporations as possible investments, always it's good to learn who else owns shares. Time Warner Inc (NYSE:TWX) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Latest News